Early Intensive Disease- Modifying Therapy Is Superior to Escalation Therapy for Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
JAMA Neurol 2019 Feb 18;[EPub Ahead of Print], K Harding, O Williams, M Willis, J Hrastelj, A Rimmer, F Joseph, V Tomassini, M Wardle, T Pickersgill, N Robertson, E TallantyreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.